Biotech | chemanager-online.com - Chemistry and Life Science

Feb. 19, 2020
Topics
Outsourcing Services: from Gene to Patient
Rentschler Biopharma SE, headquartered in Laupheim, Germany, is a leading, family-owned, full-service biopharma CDMO. Owing to agile decision making and efficient processes, Rentschler Biopharma is the preferred outsourcing partner for ...
Dec. 09, 2019
Topics
Innovative Chemistry Between Mountains and Lakes
Swiss chemical, pharmaceutical and life sciences companies help drive research around the world, and major players have research activities in the US, Singapore, Japan, as well as EU facilities in the United Kingdom and Germany. But do not ...
Dec. 06, 2019
Topics
Made in Switzerland – Exported Worldwide
The chemical, pharmaceutical and life sciences industries in Switzerland — organized in the Scienceindustries trade association — account for 45% of total exports with around 70,000 employees and are thus the undisputed ...
Nov. 06, 2019
Whitepaper
Achieving Operational Excellence with a Digital Lab
With the cost pressures and time to market challenges that the health care industry faces, pharmaceutical and biotech companies must figure out ways to increase laboratory efficiency by managing its resources more effectively. ...
Apr. 03, 2019
News & Opinions
Novartis Takes US Biotech IFM Tre
Swiss drugmaker Novartis has agreed to buy US biotech IFM Tre in a deal worth nearly $1.6 billion, boosting its portfolio of anti-inflammatory medicines. Novartis will pay $310 million upfront with IFM eligible to receive up to ...
Mar. 26, 2019
News & Opinions
Pfizer Takes Stake in French Biotech Vivet
Pfizer has taken a 15% equity stake in French privately held biotech Vivet Therapeutics, with an exclusive option to acquire the remaining shares. ...
Feb. 28, 2019
News & Opinions
Roche Pays $4.3 Billion for Spark Therapeutics
Swiss drugs giant Roche has agreed to pay $4.3 billion for Spark Therapeutics, marking the latest purchase of a biotech company by big pharma. ...
Feb. 18, 2019
News & Opinions
Celgene Wins Patent Row, Gets Generic Rival
Within a week, US biotech Celgene, which is in the process of being acquired by Bristol-Myers-Squibb (BMS), dodged a challenge to its patent for the blockbuster multiple myeloma drug Revlimid (lenalidomide) and picked up generic ...
Jan. 29, 2019
News & Opinions
DuPont Breaks Ground for Dutch Bio-Site
DuPont Industrial Biosciences has broken ground on its new multidisciplinary facility in the Leiden Bio Science Park at Oegstgeest, the Netherlands. ...
Sep. 19, 2018
Topics
Supply Security of Non-cGMP Materials
The topic of supply chain security is not a new one for the pharmaceutical industry, and much of that discussion has been dominated by the cGMP portion of the API supply chain. The discussion regularly addresses reduction of risk, superior ...

12 3 4 5 6 7 8…

Register now!

The latest information directly via newsletter.

GIT Verlag